IDH2 and glioblastoma: It is present in 79% of glioblastoma, IDH-wildtype (35) and constitutes the third molecular criteria to define glioblastoma, IDH-wildtype in an otherwise IDH-wildtype morphologically grade 2–3 diffuse astrocytoma (5).